Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.954
https://www.valueinhealthjournal.com/article/S1098-3015(16)32320-8/fulltext
Title : Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32320-8&doi=10.1016/j.jval.2016.09.954
First page : A511
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 898
Categories :
Tags :
Regions :
ViH Article Tags :